Preventing and treating progressive hearing loss
The WP2 develops innovative care pathways addressing the variable effectiveness of prosthetic treatments for sensorineural hearing loss.
To achieve this, they encompass various approaches of gene therapy, pharmacological treatments, optogenetic cochlear implants, molecular biomarker diagnostics, and robot-based surgery.